{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:48:32Z","timestamp":1781894912654,"version":"3.54.5"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dissecting the heterogeneity of schizophrenia may help foster progress in understanding its etiology and lay the groundwork for the development of new treatment options for primary or enduring negative symptoms (NS). In this regard, the present study aimed to: (1) to use cluster analysis to identify subgroups of Lebanese patients diagnosed with either schizophrenia or schizoaffective disorder based on NS clusters, and (2) to relate the statistically-derived subgroups to clinically relevant external validators (including measures if state and trait depression, stigma, insight, loneliness, social support).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>A total of 202 adult long-stay, chronic, and clinically remitted patients (166 diagnosed with schizophrenia and 36 with schizoaffective disorder) were enrolled. A cluster analysis approach was adopted to classify patients based on the five NS domains social withdrawal, emotional withdrawal, alogia, avolition and anhedonia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A three-cluster solution was obtained based on unique NS profiles, and divided patients into (1) low NS (LNS; 42.6%) which characterized by the lowest mean scores in all NS domains, (2) moderate NS (MNS; 25.7%), and (3) high NS (HNS; 31.7%). Post-hoc comparisons showed that depression (state and trait), loneliness and social support could accurately distinguish the schizophrenia subgroups. Additionally, individuals in the HNS cluster had longer duration of illness, longer duration of hospitalization, and were given higher dosages of antipsychotic medication compared to those in the other clusters, but these differences did not achieve the statistical significance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Findings provide additional support to the categorical model of schizophrenia by confirming the existence of three alternate subtypes based on NS. The determination of distinct NS subgroups within the broad heterogeneous population of people diagnosed with schizophrenia may imply that each subgroup possibly has unique underlying mechanisms and necessitates different treatment approaches.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-023-05101-3","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T14:02:50Z","timestamp":1692108170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploring negative symptoms heterogeneity in patients diagnosed with schizophrenia and schizoaffective disorder using cluster analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Feten","family":"Fekih-Romdhane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romy","family":"Hajje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadia","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souheil","family":"Hallit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyne","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"key":"5101_CR1","unstructured":"World Health Organization. Schizophrenia 2022."},{"key":"5101_CR2","doi-asserted-by":"crossref","unstructured":"Li X, et al. The global burden of schizophrenia and the impact of urbanization during 1990\u20132019: an analysis of the global burden of disease study 2019. Environmental Research; 2023. p. 116305.","DOI":"10.1016\/j.envres.2023.116305"},{"issue":"1","key":"5101_CR3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.30773\/pi.2019.0041","volume":"17","author":"SJ Cho","year":"2020","unstructured":"Cho SJ, et al. Annual prevalence and incidence of schizophrenia and similar psychotic disorders in the Republic of Korea: a national health insurance data-based study. Psychiatry Invest. 2020;17(1):61.","journal-title":"Psychiatry Invest"},{"key":"5101_CR4","doi-asserted-by":"crossref","first-page":"104964","DOI":"10.1016\/j.neubiorev.2022.104964","volume":"143","author":"A \u00c1lvarez","year":"2022","unstructured":"\u00c1lvarez A, et al. A systematic review and meta-analysis of suicidality in psychotic disorders: stratified analyses by psychotic subtypes, clinical setting and geographical region. Neurosci Biobehavioral Reviews. 2022;143:104964.","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"5101_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-clinpsy-032813-153657","volume":"10","author":"TM Laursen","year":"2014","unstructured":"Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Ann Rev Clin Psychol. 2014;10:425\u201348.","journal-title":"Ann Rev Clin Psychol"},{"issue":"3","key":"5101_CR6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11126-019-09633-4","volume":"90","author":"M Dong","year":"2019","unstructured":"Dong M, et al. Quality of life in Schizophrenia: a Meta-analysis of comparative studies. Psychiatr Q. 2019;90(3):519\u201332.","journal-title":"Psychiatr Q"},{"issue":"2","key":"5101_CR7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/schbul\/sbac103","volume":"49","author":"HG Hansen","year":"2022","unstructured":"Hansen HG, et al. Clinical recovery among individuals with a first-episode Schizophrenia an updated systematic review and Meta-analysis. Schizophr Bull. 2022;49(2):297\u2013308.","journal-title":"Schizophr Bull"},{"issue":"4","key":"5101_CR8","first-page":"252","volume":"48","author":"MA Silva","year":"2019","unstructured":"Silva MA, Restrepo D. Functional recovery in Schizophrenia. Rev Colomb Psiquiatr (Engl Ed). 2019;48(4):252\u201360.","journal-title":"Rev Colomb Psiquiatr (Engl Ed)"},{"issue":"3","key":"5101_CR9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.psychres.2011.12.051","volume":"198","author":"A Picardi","year":"2012","unstructured":"Picardi A, et al. Heterogeneity and symptom structure of schizophrenia. Psychiatry Res. 2012;198(3):386\u201394.","journal-title":"Psychiatry Res"},{"issue":"4","key":"5101_CR10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1176\/appi.ajp.2015.14091200","volume":"173","author":"BA Clementz","year":"2016","unstructured":"Clementz BA, et al. Identification of distinct psychosis biotypes using brain-based biomarkers. Am J Psychiatry. 2016;173(4):373\u201384.","journal-title":"Am J Psychiatry"},{"issue":"19","key":"5101_CR11","first-page":"E2066","volume":"111","author":"SA Meda","year":"2014","unstructured":"Meda SA, et al. Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia. Proc Natl Acad Sci. 2014;111(19):E2066\u201375.","journal-title":"Proc Natl Acad Sci"},{"key":"5101_CR12","unstructured":"Cobia D et al. Pattern classification using principal components analysis of cortical thickness in neuropsychologically defined schizophrenia subtypes. Schizophrenia bulletin. 2011. OXFORD UNIV PRESS GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND."},{"issue":"6","key":"5101_CR13","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/schbul\/sbs130","volume":"39","author":"E J\u00e4\u00e4skel\u00e4inen","year":"2013","unstructured":"J\u00e4\u00e4skel\u00e4inen E, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013;39(6):1296\u2013306.","journal-title":"Schizophr Bull"},{"issue":"1","key":"5101_CR14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/bmb\/ldv017","volume":"114","author":"J Lally","year":"2015","unstructured":"Lally J, MacCabe JH. Antipsychotic medication in schizophrenia: a review. Br Med Bull. 2015;114(1):169\u201379.","journal-title":"Br Med Bull"},{"issue":"1","key":"5101_CR15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pscychresns.2015.08.008","volume":"234","author":"D Geisler","year":"2015","unstructured":"Geisler D, et al. Brain structure and function correlates of cognitive subtypes in schizophrenia. Psychiatry Research: Neuroimaging. 2015;234(1):74\u201383.","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"5101_CR16","unstructured":"Bleuler E. Dementia praecox, oder Gruppe der Schizophrenien. Volume 1. Deuticke; 1911."},{"issue":"7","key":"5101_CR17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1982.04290070025006","volume":"39","author":"NC Andreasen","year":"1982","unstructured":"Andreasen NC, Olsen S. Negative v positive schizophrenia: definition and validation. Arch Gen Psychiatry. 1982;39(7):789\u201394.","journal-title":"Arch Gen Psychiatry"},{"key":"5101_CR18","unstructured":"Carpenter WT, Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. The American journal of psychiatry; 1988."},{"issue":"6207","key":"5101_CR19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/bmj.280.6207.66","volume":"280","author":"TJ Crow","year":"1980","unstructured":"Crow TJ. Molecular pathology of schizophrenia: more than one disease process? BMJ. 1980;280(6207):66.","journal-title":"BMJ"},{"issue":"1","key":"5101_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-1781(93)90054-K","volume":"47","author":"B Kirkpatrick","year":"1993","unstructured":"Kirkpatrick B, et al. Case identification and stability of the deficit syndrome of schizophrenia. Psychiatry Res. 1993;47(1):47\u201356.","journal-title":"Psychiatry Res"},{"key":"5101_CR21","doi-asserted-by":"crossref","unstructured":"Leonhard K. Classification of endogenous psychoses and their differentiated etiology. Springer Science & Business Media; 1999.","DOI":"10.1007\/978-3-7091-6371-9"},{"key":"5101_CR22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpsychires.2017.11.004","volume":"97","author":"AO Ahmed","year":"2018","unstructured":"Ahmed AO, et al. Schizophrenia heterogeneity revisited: clinical, cognitive, and psychosocial correlates of statistically-derived negative symptoms subgroups. J Psychiatr Res. 2018;97:8\u201315.","journal-title":"J Psychiatr Res"},{"issue":"4","key":"5101_CR23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/schbul\/sbt068","volume":"39","author":"DL Braff","year":"2013","unstructured":"Braff DL, et al. Lack of use in the literature from the last 20 years supports dropping traditional schizophrenia subtypes from DSM-5 and ICD-11. Schizophr Bull. 2013;39(4):751\u20133.","journal-title":"Schizophr Bull"},{"issue":"1\u20133","key":"5101_CR24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2008.01.022","volume":"100","author":"R Tandon","year":"2008","unstructured":"Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia,\u201cjust the facts\u201d: what we know in 2008: part 1: overview. Schizophr Res. 2008;100(1\u20133):4\u201319.","journal-title":"Schizophr Res"},{"issue":"12","key":"5101_CR25","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3109\/00048674.2011.620562","volume":"45","author":"N Korver-Nieberg","year":"2011","unstructured":"Korver-Nieberg N, et al. The validity of the DSM-IV diagnostic classification system of non-affective psychoses. Australian & New Zealand Journal of Psychiatry. 2011;45(12):1061\u20138.","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"issue":"2","key":"5101_CR26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archpsyc.58.2.165","volume":"58","author":"B Kirkpatrick","year":"2001","unstructured":"Kirkpatrick B, et al. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry. 2001;58(2):165\u201371.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"5101_CR27","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/schbul\/sbu163","volume":"41","author":"AO Ahmed","year":"2015","unstructured":"Ahmed AO, et al. Are negative symptoms dimensional or categorical? Detection and validation of deficit schizophrenia with taxometric and latent variable mixture models. Schizophr Bull. 2015;41(4):879\u201391.","journal-title":"Schizophr Bull"},{"issue":"1\u20133","key":"5101_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.005","volume":"110","author":"R Tandon","year":"2009","unstructured":"Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia,\u201cjust the facts\u201d 4. Clinical features and conceptualization. Schizophr Res. 2009;110(1\u20133):1\u201323.","journal-title":"Schizophr Res"},{"issue":"5","key":"5101_CR29","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.euroneuro.2013.10.018","volume":"24","author":"D Malaspina","year":"2014","unstructured":"Malaspina D, et al. Negative symptoms, past and present: a historical perspective and moving to DSM-5. Eur Neuropsychopharmacol. 2014;24(5):710\u201324.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"5101_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-014-0225-8","volume":"14","author":"A Sicras-Mainar","year":"2014","unstructured":"Sicras-Mainar A, et al. Impact of negative symptoms on healthcare resource utilization and associated costs in adult outpatients with schizophrenia: a population-based study. BMC Psychiatry. 2014;14(1):1\u20138.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"5101_CR31","first-page":"15446","volume":"70","author":"J Bobes","year":"2009","unstructured":"Bobes J, et al. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. J Clin Psychiatry. 2009;70(3):15446.","journal-title":"J Clin Psychiatry"},{"issue":"1\u20133","key":"5101_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2012.01.015","volume":"137","author":"J Rabinowitz","year":"2012","unstructured":"Rabinowitz J, et al. Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data. Schizophr Res. 2012;137(1\u20133):147\u201350.","journal-title":"Schizophr Res"},{"issue":"1","key":"5101_CR33","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1192\/j.eurpsy.2021.13","volume":"64","author":"S Galderisi","year":"2021","unstructured":"Galderisi S, et al. EPA guidance on treatment of negative symptoms in schizophrenia. Eur psychiatry. 2021;64(1):e21.","journal-title":"Eur psychiatry"},{"key":"5101_CR34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.schres.2016.06.024","volume":"186","author":"S Dollfus","year":"2017","unstructured":"Dollfus S, Lyne J. Negative symptoms: history of the concept and their position in diagnosis of schizophrenia. Schizophr Res. 2017;186:3\u20137.","journal-title":"Schizophr Res"},{"issue":"8","key":"5101_CR35","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S2215-0366(18)30050-6","volume":"5","author":"S Galderisi","year":"2018","unstructured":"Galderisi S, et al. Negative symptoms of schizophrenia: new developments and unanswered research questions. The Lancet Psychiatry. 2018;5(8):664\u201377.","journal-title":"The Lancet Psychiatry"},{"key":"5101_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2016.04.046","volume":"186","author":"S Galderisi","year":"2017","unstructured":"Galderisi S, F\u00e4rden A, Kaiser S. Dissecting negative symptoms of schizophrenia: history, assessment, pathophysiological mechanisms and treatment. Schizophr Res. 2017;186:1\u20132.","journal-title":"Schizophr Res"},{"key":"5101_CR37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2016.05.003","volume":"186","author":"M Kirschner","year":"2017","unstructured":"Kirschner M, Aleman A, Kaiser S. Secondary negative symptoms\u2014a review of mechanisms, assessment and treatment. Schizophr Res. 2017;186:29\u201338.","journal-title":"Schizophr Res"},{"key":"5101_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2016.05.014","volume":"186","author":"A Mucci","year":"2017","unstructured":"Mucci A, et al. Primary and persistent negative symptoms: concepts, assessments and neurobiological bases. Schizophr Res. 2017;186:19\u201328.","journal-title":"Schizophr Res"},{"issue":"3","key":"5101_CR39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/arclin\/9.3.265","volume":"9","author":"G Goldstein","year":"1994","unstructured":"Goldstein G. Neurobehavioral heterogeneity in schizophrenia. Arch Clin Neuropsychol. 1994;9(3):265\u201376.","journal-title":"Arch Clin Neuropsychol"},{"issue":"3","key":"5101_CR40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/arclin\/5.3.251","volume":"5","author":"G Goldstein","year":"1990","unstructured":"Goldstein G. Neuropsychological heterogeneity in schizophrenia: a consideration of abstraction and problem-solving abilities. Arch Clin Neuropsychol. 1990;5(3):251\u201364.","journal-title":"Arch Clin Neuropsychol"},{"key":"5101_CR41","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/978-1-4614-6744-1","volume-title":"Cluster analysis in neuropsychological research","author":"DN Allen","year":"2013","unstructured":"Allen DN, Goldstein G. Cluster analysis in neuropsychological research. Volume 10. New York, NY: Springer; 2013. pp. 978\u20131."},{"key":"5101_CR42","unstructured":"Habtewold TD et al. Schizophrenia symptoms are inherently heterogeneous: a systematic review of cluster and group-based studies bioRxiv, 2019: p.\u00a0599498."},{"key":"5101_CR43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.schres.2017.10.045","volume":"197","author":"KE Craddock","year":"2018","unstructured":"Craddock KE, et al. Symptom dimensions and subgroups in childhood-onset schizophrenia. Schizophr Res. 2018;197:71\u20137.","journal-title":"Schizophr Res"},{"key":"5101_CR44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.psychres.2016.02.003","volume":"238","author":"AM Trauelsen","year":"2016","unstructured":"Trauelsen AM, et al. Metacognition in first-episode psychosis and its association with positive and negative symptom profiles. Psychiatry Res. 2016;238:14\u201323.","journal-title":"Psychiatry Res"},{"issue":"6","key":"5101_CR45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jpsychires.2013.01.015","volume":"47","author":"GP Strauss","year":"2013","unstructured":"Strauss GP, et al. Deconstructing negative symptoms of schizophrenia: avolition\u2013apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res. 2013;47(6):783\u201390.","journal-title":"J Psychiatr Res"},{"issue":"12","key":"5101_CR46","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jamapsychiatry.2018.2475","volume":"75","author":"GP Strauss","year":"2018","unstructured":"Strauss GP, et al. The latent structure of negative symptoms in schizophrenia. JAMA psychiatry. 2018;75(12):1271\u20139.","journal-title":"JAMA psychiatry"},{"issue":"2","key":"5101_CR47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/schbul\/sby050","volume":"45","author":"AO Ahmed","year":"2019","unstructured":"Ahmed AO, et al. Cross-cultural validation of the 5-factor structure of negative symptoms in schizophrenia. Schizophr Bull. 2019;45(2):305\u201314.","journal-title":"Schizophr Bull"},{"key":"5101_CR48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2019.04.005","volume":"208","author":"M San Ang","year":"2019","unstructured":"San Ang M, Rekhi G, Lee J. Validation of the brief negative Symptom Scale and its association with functioning. Schizophr Res. 2019;208:97\u2013104.","journal-title":"Schizophr Res"},{"issue":"8","key":"5101_CR49","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.euroneuro.2019.05.006","volume":"29","author":"A Mucci","year":"2019","unstructured":"Mucci A, et al. A large european, multicenter, multinational validation study of the brief negative Symptom Scale. Eur Neuropsychopharmacol. 2019;29(8):947\u201359.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"5101_CR50","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/schbul\/sbab148","volume":"48","author":"AO Ahmed","year":"2022","unstructured":"Ahmed AO, et al. Two factors, five factors, or both? External validation studies of negative Symptom Dimensions in Schizophrenia. Schizophr Bull. 2022;48(3):620\u201330.","journal-title":"Schizophr Bull"},{"issue":"2","key":"5101_CR51","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/schbul\/sbj053","volume":"32","author":"B Kirkpatrick","year":"2006","unstructured":"Kirkpatrick B, et al. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006;32(2):214\u20139.","journal-title":"Schizophr Bull"},{"key":"5101_CR52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.schres.2022.06.021","volume":"246","author":"NB Paul","year":"2022","unstructured":"Paul NB, et al. Cluster analysis of negative symptoms identifies distinct negative symptom subgroups. Schizophr Res. 2022;246:207\u201315.","journal-title":"Schizophr Res"},{"issue":"2","key":"5101_CR53","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/schbul\/sbq059","volume":"37","author":"B Kirkpatrick","year":"2011","unstructured":"Kirkpatrick B, et al. The brief negative symptom scale: psychometric properties. Schizophr Bull. 2011;37(2):300\u20135.","journal-title":"Schizophr Bull"},{"issue":"3","key":"5101_CR54","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/schbul\/sbv161","volume":"42","author":"S Dollfus","year":"2016","unstructured":"Dollfus S, Mach C, Morello R. Self-evaluation of negative symptoms: a Novel Tool to assess negative symptoms. Schizophr Bull. 2016;42(3):571\u20138.","journal-title":"Schizophr Bull"},{"issue":"3","key":"5101_CR55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0010-440X(00)90047-6","volume":"41","author":"JP Selten","year":"2000","unstructured":"Selten JP, Wiersma D, van den Bosch RJ. Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms. Compr Psychiatry. 2000;41(3):191\u20136.","journal-title":"Compr Psychiatry"},{"issue":"2\u20133","key":"5101_CR56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0920-9964(95)00100-X","volume":"19","author":"EK Hamera","year":"1996","unstructured":"Hamera EK, et al. Validity of self-administered symptom scales in clients with schizophrenia and schizoaffective disorders. Schizophr Res. 1996;19(2\u20133):213\u20139.","journal-title":"Schizophr Res"},{"issue":"Suppl 44","key":"5101_CR57","first-page":"5","volume":"55","author":"E Lindstr\u00f6m","year":"2001","unstructured":"Lindstr\u00f6m E, et al. Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat). Nord J Psychiatry. 2001;55(Suppl 44):5\u201369.","journal-title":"Nord J Psychiatry"},{"key":"5101_CR58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.schres.2019.07.012","volume":"211","author":"S Dollfus","year":"2019","unstructured":"Dollfus S, et al. Specificity and sensitivity of the self-assessment of negative symptoms (SNS) in patients with schizophrenia. Schizophr Res. 2019;211:51\u20135.","journal-title":"Schizophr Res"},{"issue":"6","key":"5101_CR59","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.encep.2017.10.002","volume":"44","author":"C Hervochon","year":"2017","unstructured":"Hervochon C, et al. Validation of the french version of the self-evaluation of negative symptoms (SNS). L\u2019encephale. 2017;44(6):512\u20136.","journal-title":"L\u2019encephale"},{"key":"5101_CR60","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"AP Association","year":"2013","unstructured":"American Psychiatric Association, A. and, Association AP. Diagnostic and statistical manual of mental disorders: DSM-5. Volume 10. Washington, DC: American psychiatric association; 2013."},{"issue":"2","key":"5101_CR61","first-page":"18","volume":"6","author":"A Banerjee","year":"2012","unstructured":"Banerjee A. Cross-cultural variance of schizophrenia in symptoms, diagnosis and treatment. Georget Univ J Health Sci. 2012;6(2):18\u201324.","journal-title":"Georget Univ J Health Sci"},{"issue":"4","key":"5101_CR62","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/oxfordjournals.schbul.a006974","volume":"28","author":"SW Bae","year":"2002","unstructured":"Bae SW, Brekke JS. Characteristics of korean-americans with schizophrenia: a cross-ethnic comparison with African-Americans, Latinos, and Euro-Americans. Schizophr Bull. 2002;28(4):703\u201317.","journal-title":"Schizophr Bull"},{"issue":"2","key":"5101_CR63","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/schbul\/23.2.305","volume":"23","author":"JS Brekke","year":"1997","unstructured":"Brekke JS, Barrio C. Cross-ethnic symptom differences in schizophrenia: the influence of culture and minority status. Schizophr Bull. 1997;23(2):305\u201316.","journal-title":"Schizophr Bull"},{"issue":"9","key":"5101_CR64","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/01.nmd.0000140035.36075.7f","volume":"192","author":"SW Bae","year":"2004","unstructured":"Bae SW, Brekke JS, Bola JR. Ethnicity and treatment outcome variation in schizophrenia: a longitudinal study of community-based psychosocial rehabilitation interventions. J Nerv Ment Dis. 2004;192(9):623\u20138.","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"5101_CR65","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12888-023-04531-3","volume":"23","author":"C Rahme","year":"2023","unstructured":"Rahme C, El Kadri N, Haddad C, Fekih-Romdhane F, Obeid S, Hallit S. Exploring the association between lifetime traumatic experiences and positive psychotic symptoms in a group of long-stay patients with schizophrenia: the mediating effect of depression, anxiety, and distress. BMC Psychiatry. 2023;23(1):29. https:\/\/doi.org\/10.1186\/s12888-023-04531-3.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"5101_CR66","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12888-023-04711-1","volume":"23","author":"C Beainy","year":"2023","unstructured":"Beainy C, Haddad C, Fekih-Romdhane F, Hallit S, Haddad G. Decreased insight, but not self-stigma or belief about medicine, is associated with greater severity of delusions in a sample of long-stay patients with schizophrenia: a cross-sectional study. BMC Psychiatry. 2023;23(1):222. https:\/\/doi.org\/10.1186\/s12888-023-04711-1.","journal-title":"BMC Psychiatry"},{"issue":"6","key":"5101_CR67","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1377\/hlthaff.20.6.267","volume":"20","author":"W Hwang","year":"2001","unstructured":"Hwang W, et al. Out-of-pocket medical spending for care of chronic conditions. Health Aff. 2001;20(6):267\u201378.","journal-title":"Health Aff"},{"issue":"2","key":"5101_CR68","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1192\/bjp.187.2.131","volume":"187","author":"WW Fleischhacker","year":"2005","unstructured":"Fleischhacker WW, et al. Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year. Br J Psychiatry. 2005;187(2):131\u20136.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"5101_CR69","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/13651501.2019.1682615","volume":"24","author":"S Obeid","year":"2020","unstructured":"Obeid S, Hallit S, Sacre H, Kazour GR. Effectiveness of integrated psychological therapy on cognitive function among Lebanese patients with schizophrenia: a pilot study. Int J Psychiatry Clin Pract. 2020;24(1):43\u201352. https:\/\/doi.org\/10.1080\/13651501.2019.1682615.","journal-title":"Int J Psychiatry Clin Pract"},{"key":"5101_CR70","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11136-015-1110-8","volume":"25","author":"C Rutherford","year":"2016","unstructured":"Rutherford C, et al. Mode of administration does not cause bias in patient-reported outcome results: a meta-analysis. Qual Life Res. 2016;25:559\u201374.","journal-title":"Qual Life Res"},{"issue":"1","key":"5101_CR71","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/schbul\/sbt069","volume":"40","author":"J Chiappelli","year":"2014","unstructured":"Chiappelli J, et al. Assessment of trait and state aspects of depression in schizophrenia. Schizophr Bull. 2014;40(1):132\u201342.","journal-title":"Schizophr Bull"},{"issue":"1","key":"5101_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-020-02647-4","volume":"20","author":"A Hajj","year":"2020","unstructured":"Hajj A, Hallit S, Chamoun K, Sacre H, Obeid S, Haddad C, Dollfus S, Rabbaa Khabbaz L. Validation of the Arabic version of the \"self-evaluation of negative symptoms\" scale (SNS). BMC Psychiatry. 2020;20(1):240. https:\/\/doi.org\/10.1186\/s12888-020-02647-4.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"5101_CR73","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/archpsyc.64.2.234","volume":"64","author":"RS Wilson","year":"2007","unstructured":"Wilson RS, et al. Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry. 2007;64(2):234\u201340.","journal-title":"Arch Gen Psychiatry"},{"key":"5101_CR74","doi-asserted-by":"publisher","unstructured":"Awad E, Rogoza R, Gerges S, Obeid S, Hallit S. Association of Social Media Use Disorder and Orthorexia Nervosa Among Lebanese University Students: The Indirect Effect of Loneliness and Factor Structure of the Social Media Use Disorder Short Form and the Jong-Gierveld Loneliness Scales. Psychol Rep. 2022:332941221132985. https:\/\/doi.org\/10.1177\/00332941221132985..","DOI":"10.1177\/00332941221132985"},{"issue":"1","key":"5101_CR75","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-0447.1994.tb01487.x","volume":"89","author":"M Birchwood","year":"1994","unstructured":"Birchwood M, et al. A self-report insight scale for psychosis: reliability, validity and sensitivity to change. Acta psychiatrica Scandinavica. 1994;89(1):62\u20137.","journal-title":"Acta psychiatrica Scandinavica"},{"key":"5101_CR76","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.psychres.2018.12.072","volume":"272","author":"CB B\u00fcchmann","year":"2019","unstructured":"B\u00fcchmann CB, et al. Validity of the Birchwood insight scale in patients with schizophrenia spectrum-and bipolar disorders. Psychiatry Res. 2019;272:715\u201322.","journal-title":"Psychiatry Res"},{"issue":"1","key":"5101_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-016-0825-6","volume":"16","author":"Y Tanabe","year":"2016","unstructured":"Tanabe Y, Hayashi K, Ideno Y. The internalized stigma of Mental Illness (ISMI) scale: validation of the japanese version. BMC Psychiatry. 2016;16(1):1\u20138.","journal-title":"BMC Psychiatry"},{"issue":"5","key":"5101_CR78","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/1363461515569755","volume":"52","author":"IA Kira","year":"2015","unstructured":"Kira IA, et al. Psychometric assessment of the arabic version of the internalized stigma of Mental Illness (ISMI) measure in a refugee population. Transcult Psychiatry. 2015;52(5):636\u201358.","journal-title":"Transcult Psychiatry"},{"issue":"1","key":"5101_CR79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40359-017-0211-2","volume":"6","author":"R-D Kocalevent","year":"2018","unstructured":"Kocalevent R-D, et al. Social support in the general population: standardization of the Oslo social support scale (OSSS-3). BMC Psychol. 2018;6(1):1\u20138.","journal-title":"BMC Psychol"},{"issue":"2","key":"5101_CR80","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","volume":"8","author":"D Wild","year":"2005","unstructured":"Wild D, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value in health. 2005;8(2):94\u2013104.","journal-title":"Value in health"},{"issue":"24","key":"5101_CR81","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1097\/00007632-200012150-00014","volume":"25","author":"DE Beaton","year":"2000","unstructured":"Beaton DE, et al. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186\u201391.","journal-title":"Spine"},{"key":"5101_CR82","first-page":"1","volume-title":"Recommendations for the cross-cultural adaptation of health status measures","author":"D Beaton","year":"2002","unstructured":"Beaton D, et al. Recommendations for the cross-cultural adaptation of health status measures. New York: American Academy of Orthopaedic Surgeons; 2002. pp. 1\u20139."},{"issue":"3","key":"5101_CR83","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/heapro\/dat002","volume":"29","author":"H Al-Bannay","year":"2013","unstructured":"Al-Bannay H, et al. Culture as a variable in health research: perspectives and caveats. Health Promot Int. 2013;29(3):549\u201357.","journal-title":"Health Promot Int"},{"key":"5101_CR84","volume-title":"The palliative care outcome scale (POS) manual for cross-cultural adaptation and psychometric validation","author":"B Antunes","year":"2012","unstructured":"Antunes B, et al. The palliative care outcome scale (POS) manual for cross-cultural adaptation and psychometric validation. London: Cicely Saunders Institute; 2012."},{"key":"5101_CR85","unstructured":"Weidmer B. Issues and guidelines for translation in cross-cultural research. in Proceedings of the American Statistical Association, Section on Survey Research Methods. 1994."},{"issue":"2","key":"5101_CR86","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2648.2004.03185.x","volume":"48","author":"W Maneesriwongul","year":"2004","unstructured":"Maneesriwongul W, Dixon JK. Instrument translation process: a methods review. J Adv Nurs. 2004;48(2):175\u201386.","journal-title":"J Adv Nurs"},{"issue":"1","key":"5101_CR87","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/1756-0500-7-228","volume":"7","author":"C Nejjari","year":"2014","unstructured":"Nejjari C, et al. Translation and validation of european organization for research and treatment of cancer quality of life Questionnaire-C30 into moroccan version for cancer patients in Morocco. BMC Res Notes. 2014;7(1):228.","journal-title":"BMC Res Notes"},{"issue":"2","key":"5101_CR88","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/0019-5545.111475","volume":"55","author":"V Danivas","year":"2013","unstructured":"Danivas V, Venkatasubramanian G. Current perspectives on chlorpromazine equivalents: comparing apples and oranges! Indian J psychiatry. 2013;55(2):207.","journal-title":"Indian J psychiatry"},{"key":"5101_CR89","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02293899","volume":"46","author":"GW Milligan","year":"1981","unstructured":"Milligan GW. A Monte Carlo study of thirty internal criterion measures for cluster analysis. Psychometrika. 1981;46:187\u201399.","journal-title":"Psychometrika"},{"issue":"1","key":"5101_CR90","doi-asserted-by":"crossref","first-page":"8","DOI":"10.20982\/tqmp.11.1.p008","volume":"11","author":"O Yim","year":"2015","unstructured":"Yim O, Ramdeen KT. Hierarchical cluster analysis: comparison of three linkage measures and application to psychological data. Quant methods Psychol. 2015;11(1):8\u201321.","journal-title":"Quant methods Psychol"},{"issue":"1","key":"5101_CR91","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00521-021-05873-3","volume":"34","author":"A Karna","year":"2022","unstructured":"Karna A, Gibert K. Automatic identification of the number of clusters in hierarchical clustering. Neural Comput Appl. 2022;34(1):119\u201334.","journal-title":"Neural Comput Appl"},{"issue":"1","key":"5101_CR92","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s40337-022-00673-z","volume":"10","author":"E Yakin","year":"2022","unstructured":"Yakin E, et al. -between orthorexia\u201d profile: the co-occurrence of pathological and healthy orthorexia among male and female non-clinical adolescents. J Eat Disord. 2022;10(1):155.","journal-title":"J Eat Disord"},{"key":"5101_CR93","unstructured":"Hair JF Jr, et al. Advanced issues in partial least squares structural equation modeling. saGe publications; 2017."},{"key":"5101_CR94","unstructured":"Cohen J. The effect size Statistical power analysis for the behavioral sciences, 1988: p.\u00a077\u201383."},{"issue":"3","key":"5101_CR95","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/schbul\/22.3.545","volume":"22","author":"S Dollfus","year":"1996","unstructured":"Dollfus S, et al. Identifying subtypes of schizophrenia by cluster analyses. Schizophr Bull. 1996;22(3):545\u201355.","journal-title":"Schizophr Bull"},{"issue":"1\u20132","key":"5101_CR96","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0920-9964(01)00251-1","volume":"56","author":"H-G Hwu","year":"2002","unstructured":"Hwu H-G, et al. Symptom patterns and subgrouping of schizophrenic patients: significance of negative symptoms assessed on admission. Schizophr Res. 2002;56(1\u20132):105\u201319.","journal-title":"Schizophr Res"},{"issue":"2\u20133","key":"5101_CR97","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.schres.2005.03.022","volume":"77","author":"JJ Blanchard","year":"2005","unstructured":"Blanchard JJ, Horan WP, Collins LM. Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia? Schizophr Res. 2005;77(2\u20133):151\u201365.","journal-title":"Schizophr Res"},{"key":"5101_CR98","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.schres.2018.06.060","volume":"202","author":"JJ Crouse","year":"2018","unstructured":"Crouse JJ, et al. Parcellating cognitive heterogeneity in early psychosis-spectrum illnesses: a cluster analysis. Schizophr Res. 2018;202:91\u20138.","journal-title":"Schizophr Res"},{"issue":"1\u20133","key":"5101_CR99","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.schres.2016.04.017","volume":"174","author":"B Gee","year":"2016","unstructured":"Gee B, et al. The course of negative symptom in first episode psychosis and the relationship with social recovery. Schizophr Res. 2016;174(1\u20133):165\u201371.","journal-title":"Schizophr Res"},{"issue":"5","key":"5101_CR100","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/acps.12873","volume":"137","author":"CR Krynicki","year":"2018","unstructured":"Krynicki CR, et al. The relationship between negative symptoms and depression in schizophrenia: a systematic review. Acta psychiatrica Scandinavica. 2018;137(5):380\u201390.","journal-title":"Acta psychiatrica Scandinavica"},{"issue":"15","key":"5101_CR101","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1017\/S0033291719002381","volume":"49","author":"CJ Edwards","year":"2019","unstructured":"Edwards CJ, Garety P, Hardy A. The relationship between depressive symptoms and negative symptoms in people with non-affective psychosis: a meta-analysis. Psychol Med. 2019;49(15):2486\u201398.","journal-title":"Psychol Med"},{"issue":"S7","key":"5101_CR102","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/S0007125000291496","volume":"155","author":"NC Andreasen","year":"1989","unstructured":"Andreasen NC. The Scale for the Assessment of negative symptoms (SANS): conceptual and theoretical foundations. Br J psychiatry. 1989;155(S7):49\u201352.","journal-title":"Br J psychiatry"},{"issue":"3","key":"5101_CR103","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1192\/apt.6.3.169","volume":"6","author":"C Mulholland","year":"2000","unstructured":"Mulholland C, Cooper S. The symptom of depression in schizophrenia and its management. Adv Psychiatr Treat. 2000;6(3):169\u201377.","journal-title":"Adv Psychiatr Treat"},{"issue":"2","key":"5101_CR104","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/schbul\/sbn135","volume":"35","author":"PF Buckley","year":"2009","unstructured":"Buckley PF, et al. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009;35(2):383\u2013402.","journal-title":"Schizophr Bull"},{"issue":"1\u20133","key":"5101_CR105","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.schres.2012.01.031","volume":"137","author":"R Wallwork","year":"2012","unstructured":"Wallwork R, et al. Searching for a consensus five-factor model of the positive and negative syndrome scale for schizophrenia. Schizophr Res. 2012;137(1\u20133):246\u201350.","journal-title":"Schizophr Res"},{"issue":"1\u20132","key":"5101_CR106","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0920-9964(95)00107-7","volume":"20","author":"AA Collins","year":"1996","unstructured":"Collins AA, et al. Depression in schizophrenia: a comparison of three measures. Schizophr Res. 1996;20(1\u20132):205\u20139.","journal-title":"Schizophr Res"},{"key":"5101_CR107","doi-asserted-by":"crossref","unstructured":"Wright ER, Gronfein WP, Owens TJ. Deinstitutionalization, social rejection, and the self-esteem of former mental patients. J Health Soc Behav, 2000: p. 68\u201390.","DOI":"10.2307\/2676361"},{"issue":"1\u20133","key":"5101_CR108","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.schres.2009.01.015","volume":"110","author":"PH Lysaker","year":"2009","unstructured":"Lysaker PH, Vohs JL, Tsai J. Negative symptoms and concordant impairments in attention in schizophrenia: associations with social functioning, hope, self-esteem and internalized stigma. Schizophr Res. 2009;110(1\u20133):165\u201372.","journal-title":"Schizophr Res"},{"issue":"3","key":"5101_CR109","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/j.2051-5545.2008.tb00181.x","volume":"7","author":"B Kirkpatrick","year":"2008","unstructured":"Kirkpatrick B, Galderisi S. Deficit schizophrenia: an update. World Psychiatry. 2008;7(3):143.","journal-title":"World Psychiatry"},{"issue":"13","key":"5101_CR110","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s40265-017-0789-y","volume":"77","author":"SRT Veerman","year":"2017","unstructured":"Veerman SRT, Schulte PFJ, de Haan L. Treatment for negative symptoms in Schizophrenia: a Comprehensive Review. Drugs. 2017;77(13):1423\u201359.","journal-title":"Drugs"},{"issue":"6","key":"5101_CR111","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.12740\/PP\/36019","volume":"49","author":"B Paw\u0142owska","year":"2015","unstructured":"Paw\u0142owska B, et al. Changes to psychosocial functioning as demonstrated by the patients diagnosed with schizophrenia covered by the psychiatric rehabilitation system. Psychiatr Pol. 2015;49(6):1191\u2013202.","journal-title":"Psychiatr Pol"},{"issue":"5","key":"5101_CR112","first-page":"625","volume":"19","author":"LH Ossman","year":"2012","unstructured":"Ossman LH, Mahmoud NM. Social support and length of hospital stay among schizophrenic patients. World Appl Sci J. 2012;19(5):625\u201333.","journal-title":"World Appl Sci J"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-05101-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-023-05101-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-05101-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T17:15:47Z","timestamp":1700241347000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-023-05101-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5101"],"URL":"https:\/\/doi.org\/10.1186\/s12888-023-05101-3","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"assertion":[{"value":"16 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Psychiatric Hospital of the Cross Ethics and Research Committee approved the study protocol (HPC-022-2021). Written informed consent was obtained from all patients or the parent and\/or legal guardian of the participants in case of inability to consent. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"595"}}